was read the article
array:24 [ "pii" => "S0325754116000110" "issn" => "03257541" "doi" => "10.1016/j.ram.2016.02.006" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "92" "copyright" => "Asociación Argentina de Microbiología" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Argent Microbiol. 2016;48:110-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1716 "formatos" => array:3 [ "EPUB" => 30 "HTML" => 971 "PDF" => 715 ] ] "itemSiguiente" => array:19 [ "pii" => "S0325754116000109" "issn" => "03257541" "doi" => "10.1016/j.ram.2016.02.005" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "91" "copyright" => "Asociación Argentina de Microbiología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Argent Microbiol. 2016;48:119-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1350 "formatos" => array:3 [ "EPUB" => 31 "HTML" => 887 "PDF" => 432 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Informe breve</span>" "titulo" => "Absceso de psoas por <span class="elsevierStyleItalic">Staphylococcus lugdunensis</span>" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "119" "paginaFinal" => "121" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Psoas abscess caused by <span class="elsevierStyleItalic">Staphylococcus lugdunensis</span>" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1275 "Ancho" => 1700 "Tamanyo" => 239135 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A) Artritis infecciosa, dependiendo de la articulación facetaria derecha del nivel L4-L5, con colecciones abscesificadas en el área adyacente al músculo psoas derecho en L4-L5 (flecha), y en el espacio epidural izquierdo en L5-S1, con afectación de partes blandas adyacentes (punta de flecha). B) Desaparición de las colecciones abscesificadas (flecha). Persistencia de alteración de señal de la articulación facetaria L4-L5, y mínimo edema de partes blandas (punta de flecha).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Tamargo Delpón, Pablo Demelo-Rodríguez, Juan Carlos Cano Ballesteros, Laura Vela de la Cruz" "autores" => array:4 [ 0 => array:2 [ "nombre" => "María" "apellidos" => "Tamargo Delpón" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Demelo-Rodríguez" ] 2 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Cano Ballesteros" ] 3 => array:2 [ "nombre" => "Laura" "apellidos" => "Vela de la Cruz" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0325754116000109?idApp=UINPBA00004N" "url" => "/03257541/0000004800000002/v1_201607030039/S0325754116000109/v1_201607030039/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S032575411600002X" "issn" => "03257541" "doi" => "10.1016/j.ram.2015.12.003" "estado" => "S300" "fechaPublicacion" => "2016-04-01" "aid" => "83" "copyright" => "Asociación Argentina de Microbiología" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Argent Microbiol. 2016;48:105-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1430 "formatos" => array:3 [ "EPUB" => 40 "HTML" => 1112 "PDF" => 278 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief reports</span>" "titulo" => "<span class="elsevierStyleItalic">Arcobacter butzleri</span> survives within trophozoite of <span class="elsevierStyleItalic">Acanthamoeba castellanii</span>" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "105" "paginaFinal" => "109" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "<span class="elsevierStyleItalic">Arcobacter butzleri</span> sobrevive en el interior de trofozoitos de <span class="elsevierStyleItalic">Acanthamoeba castellanii</span>" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1009 "Ancho" => 2040 "Tamanyo" => 261224 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Phase contrast microscopy. (A) Trophozoite of <span class="elsevierStyleItalic">A. castellanii</span> showing <span class="elsevierStyleItalic">A. butzleri</span> seen in close association with <span class="elsevierStyleItalic">A. castellanii</span> gathering at one pole of the amoeba cell known as food-cup (30<span class="elsevierStyleHsp" style=""></span>min of co-incubation). (B) Trophozoite of <span class="elsevierStyleItalic">A. castellanii</span> showing <span class="elsevierStyleItalic">A. butzleri</span> within the amoebic vacuoles (50<span class="elsevierStyleHsp" style=""></span>min of co-incubation).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María P. Villanueva, Gustavo Medina, Heriberto Fernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "María P." "apellidos" => "Villanueva" ] 1 => array:2 [ "nombre" => "Gustavo" "apellidos" => "Medina" ] 2 => array:2 [ "nombre" => "Heriberto" "apellidos" => "Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S032575411600002X?idApp=UINPBA00004N" "url" => "/03257541/0000004800000002/v1_201607030039/S032575411600002X/v1_201607030039/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "<span class="elsevierStyleItalic">Epstein–Barr virus</span> load in transplant patients: Early detection of post-transplant lymphoproliferative disorders" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "110" "paginaFinal" => "118" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "María Dolores Fellner, Karina A. Durand, Veronica Solernou, Andrea Bosaleh, Ziomara Balbarrey, María T. García de Dávila, Marcelo Rodríguez, Lucía Irazu, Lidia V. Alonio, María A. Picconi" "autores" => array:10 [ 0 => array:4 [ "nombre" => "María Dolores" "apellidos" => "Fellner" "email" => array:1 [ 0 => "oncovir1@anlis.gov.ar" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Karina A." "apellidos" => "Durand" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Veronica" "apellidos" => "Solernou" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Andrea" "apellidos" => "Bosaleh" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "Ziomara" "apellidos" => "Balbarrey" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "María T." "apellidos" => "García de Dávila" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 6 => array:3 [ "nombre" => "Marcelo" "apellidos" => "Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 7 => array:3 [ "nombre" => "Lucía" "apellidos" => "Irazu" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 8 => array:3 [ "nombre" => "Lidia V." "apellidos" => "Alonio" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 9 => array:3 [ "nombre" => "María A." "apellidos" => "Picconi" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Oncogenic Viruses Service, Virology Department, “Carlos G. Malbrán” National Institute of Infectious Diseases, Av. Vélez Sársfield 563, C1282AFF Buenos Aires, Argentina" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Pathology Service, “Prof. Dr. Juan. P. Garrahan” National Pediatrics Hospital, Pichincha 1890, C1249ABP Buenos Aires, Argentina" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Operational Team Quality Management, Parasitology Department, “Carlos G. Malbrán” National Institute of Infectious Diseases, Av. Vélez Sársfield 563, C1282AFF Buenos Aires, Argentina" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carga de virus <span class="elsevierStyleItalic">Epstein-Barr</span> en pacientes trasplantados: detección temprana de desórdenes linfoproliferativos postrasplante" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 697 "Ancho" => 2532 "Tamanyo" => 132852 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Analysis of the EBV load from plasma samples. The plasma EBV load showed high specificity to detect all PTLD; while an increasing sensitivity was noted as PTLD stages progressed. Total PTLD: included categories 1–4 (A); advanced PTLD: categories 2–4 (B).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The <span class="elsevierStyleItalic">Epstein–Barr virus</span> (EBV) infection is associated with the development of post-transplant lymphoproliferative disorders (PTLD) in solid-organ and stem cell transplant recipients<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">17</span></a>.</p><p id="par0010" class="elsevierStylePara elsevierViewall">PTLD encompass a wide range of disorders including benign to malignant lymphoproliferations<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">22</span></a>. Briefly, category 1 includes early benign PTLD; category 2, benign and neoplastic PTLD and categories 3 and 4, neoplastic PTLD. It had been noted that a therapeutic intervention, particularly during the early PTLD phases, could reverse lymphoproliferation and prevent progression to the irreversible lymphoma stage<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">3</span></a>.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The association of PTLD and elevated levels of circulating EBV were first described in the nineties<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">18</span></a>. Since then, different authors showed that PTLD, especially those occurring early after transplantation, are generally associated with an increase in EBV DNA in peripheral blood samples. This has led to using the EBV load as a risk marker for this disease<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">7,8,10</span></a>.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Initially, many studies explored the clinical usefulness of these tests in a single sample in the presence of disease<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">19,20</span></a>. Then, the importance of surveillance through frequent repetitive monitoring was brought up<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">11</span></a>. At present, a high viral load is used for two purposes: an <span class="elsevierStyleItalic">early diagnosis</span> (indicating when to start the search for disease in a potential site), and as a <span class="elsevierStyleItalic">prevention strategy</span> (indicating when to therapeutically intervene)<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">6,10</span></a>. Furthermore, some authors have proposed to calculate an average load in a set time, rather than use a single cut-off value<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">6</span></a>. Thus, a reduction in PTLD morbidity and mortality was reported in centers that had implemented systematic EBV load monitoring, and the viral burden was maintained at levels defined as “low”, by regulating the degree of immunosuppression<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">12</span></a>.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In the literature, the definition of a threshold indicative of a “high load” is inconsistent because each laboratory has implemented its own cut-off values to distinguish PTLD from baseline levels<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">13</span></a>. The broad diversity of methods (type of quantitative PCR, amplified viral fragment), type and quantity of clinical sample analyzed (peripheral blood mononuclear cells, PBMC; whole blood; plasma), controls used to standardize assays, expression of results (number of viral genome equivalents per number of cells, DNA quantity, volume), sampling frequency, among others, have made it difficult to compare published data and extrapolate cut-off values from one laboratory to another. Therefore, the overall sensitivity, specificity, positive and negative predictive values obtained by different authors relied on the population studied (adult <span class="elsevierStyleItalic">vs</span>. pediatric), type of transplanted organ (solid organ <span class="elsevierStyleItalic">vs</span>. stem cells), pre-transplant infection status, among others.</p><p id="par0030" class="elsevierStylePara elsevierViewall">An assay to quantify EBV by real-time PCR was developed in our laboratory to monitor transplant patients<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">5</span></a>. Thus, considering the lack of consensus on the EBV level that identifies PTLD, the optimal type of clinical sample, and using the logistics implemented to handle transplant patients’ samples in our laboratory (already underway using a semi-quantitative PCR)<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">4</span></a>, the EBV load in this report was analyzed in different clinical specimens, which also represent anatomical sites of viral persistence. Therefore, the aim of this study was to clinically validate the developed EBV quantification assay for the early detection of PTLD in transplant patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Materials and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Patients and samples</span><p id="par0035" class="elsevierStylePara elsevierViewall">Pediatric recipients of solid organ transplants treated at “Prof. Dr Juan P. Garrahan” Pediatric Hospital, Austral University Hospital, Sor María Ludovica Children's Hospital and Favaloro Foundation between 2001 and 2010 were selected for inclusion in the present study. All patients were found to be infected with EBV, as established by the previous detection of IgG antibodies against viral capsid antigen and/or EBV-DNA in PBMC. Samples were obtained according to the monitoring of transplanted patients or treatment protocol and their selection was based on clinical data (presence or absence of signs and symptoms associated with EBV infection), previous EBV load results acquired by semi-quantitative PCR<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">4</span></a> (including varying EBV load levels: low, high and very high) and histopathological examination of biopsy material (PTLD or a different diagnosis based on the corresponding lymphoid tissue).</p><p id="par0040" class="elsevierStylePara elsevierViewall">An informed consent was obtained from all patients in accordance with the Helsinki declaration and other national or international regulations. All procedures were approved by the Ethical Research Committee, National Center of Medical Genetics, ANLIS “Dr. Carlos G. Malbrán”.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Transversal study design</span><p id="par0045" class="elsevierStylePara elsevierViewall">Paired peripheral blood and oropharyngeal lymphoid tissue (OLT) samples from 105 pediatric solid-organ transplant recipients were included. Fifty-eight of them were histologically diagnosed with PTLD, according to the World Health Organization classification: IARC, 2008<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">22</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Retrospective follow-up study design</span><p id="par0050" class="elsevierStylePara elsevierViewall">Seventy one paired PBMC and plasma samples were included from six organ recipients with a histological diagnosis of PTLD, and six transplant patients with a variety of clinical conditions associated with EBV, but not with PTLD.</p><p id="par0055" class="elsevierStylePara elsevierViewall">PBMC and plasma were separated from 2.5 to 5<span class="elsevierStyleHsp" style=""></span>ml of EDTA-anticoagulated whole blood samples by centrifugation on a density gradient (Histopaque-1077, Sigma–Aldrich) as recommended, and then stored at −20<span class="elsevierStyleHsp" style=""></span>°C. The OLT from patients with lymphoid hypertrophy were surgically removed and immediately stored at −80<span class="elsevierStyleHsp" style=""></span>°C.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">DNA extraction</span><p id="par0060" class="elsevierStylePara elsevierViewall">DNA from PBMC and OLT samples was obtained as previously reported<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">4</span></a>.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Plasma DNA was extracted using the QIAmp DNA mini kit (QIAgen, Hilden, Germany) following manufacturers’ recommendations for free viral DNA extraction.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">EBV DNA quantification</span><p id="par0070" class="elsevierStylePara elsevierViewall">We applied a duplex real-time PCR assay that simultaneously amplifies an EBNA-1 coding gene portion and one of the human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) encoding genes; the amplification was performed as previously described<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">5</span></a>.</p><p id="par0075" class="elsevierStylePara elsevierViewall">The primers/probes were as follows:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><p id="par0080" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">EBV reaction</span>: 5′ CCGCTCCTACCTGCAATATCA 3′ (forward primer) and 5′ GGAAACCAGGGAGGCAAATC 3′ (reverse primer); 5′ VIC-TGCAGCTTTGACGATGG-MGB 3′ (probe). They amplified a 73<span class="elsevierStyleHsp" style=""></span>bp fragment.</p></li><li class="elsevierStyleListItem" id="lsti0010"><p id="par0085" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">GAPDH reaction</span>: 5′ GGTGGTCTCCTCTGACTTCAACA 3′ (forward primer); 5′ GTGGTCGTTGAGGGCAATG 3′ (reverse primer) and 5′ FAM-CCACTCCTCCACCTTTGACGCTGG-3′ TAMRA (probe). They amplified a 79<span class="elsevierStyleHsp" style=""></span>bp fragment.</p></li></ul></p><p id="par0090" class="elsevierStylePara elsevierViewall">Amplification was performed in a final reaction volume of 25<span class="elsevierStyleHsp" style=""></span>μl, containing 1× TaqMan Universal Master Mix with AmpErase UNG (Applied Biosystems, New Jersey, USA), 0.3<span class="elsevierStyleHsp" style=""></span>μM of EBV-primers, 0.05<span class="elsevierStyleHsp" style=""></span>μM of GAPDH-primers, 0.1<span class="elsevierStyleHsp" style=""></span>μM of EBV-probe and GAPDH-probe (Applied Biosystems, Foster city, USA) and the DNA to be amplified.</p><p id="par0095" class="elsevierStylePara elsevierViewall">For each reaction around 366<span class="elsevierStyleHsp" style=""></span>ng of DNA were assayed (corresponding to the amount of DNA of 10<span class="elsevierStyleSup">5</span> human cells<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">4</span></a>) from PBMC or OLT or the extracted DNA from 30<span class="elsevierStyleHsp" style=""></span>μl of plasma. The amplification was performed using a 7500 real-time PCR System (Applied Biosystems) under the following cycle conditions: 50<span class="elsevierStyleHsp" style=""></span>°C 2<span class="elsevierStyleHsp" style=""></span>min; 95<span class="elsevierStyleHsp" style=""></span>°C 10<span class="elsevierStyleHsp" style=""></span>min followed by 45 cycles of 95<span class="elsevierStyleHsp" style=""></span>°C 15<span class="elsevierStyleHsp" style=""></span>s, 60<span class="elsevierStyleHsp" style=""></span>°C 1<span class="elsevierStyleHsp" style=""></span>min.</p><p id="par0100" class="elsevierStylePara elsevierViewall">The EBV load measured in PBMC DNA was expressed as the number of EBV genome equivalents (gEq) per 10<span class="elsevierStyleSup">5</span> PBMC. The normalized EBV load was estimated from the results of the EBNA-1 and GAPDH reactions (EBNA<span class="elsevierStyleHsp" style=""></span>−<span class="elsevierStyleHsp" style=""></span>1 load/GAPDH load<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleSup">5</span>). The EBV load in plasma was expressed as the number of EBV gEq per ml of plasma by multiplying the EBNA-1 load by a factor of 33.3 and correcting by extraction efficiency.</p><p id="par0105" class="elsevierStylePara elsevierViewall">Kinetic variation was defined as a greater than 0.5<span class="elsevierStyleHsp" style=""></span>log unit increase or decrease with respect to the EBV load measured in a previous sample. This implies a load variation greater than the overall precision of the method<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">5</span></a> and also relies on the concept that a difference higher than 0.5<span class="elsevierStyleHsp" style=""></span>log units is clinically significant<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">9</span></a>.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Clinical validation</span><p id="par0110" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Transversal study:</span> it was done in order to analyze the diagnostic performance of different cut-off values as PTLD indicators. The diagnostic ability of the assay for detecting total PTLD (including categories 1–4), advanced PTLD (categories 2–4), or neoplastic PTLD (categories 3 and 4) cases (positive reference population) was evaluated analyzing the sensitivity and specificity of different EBV load levels. The organ recipients without PTLD were considered the negative reference population. Paired PBMC, plasma and OLT samples were analyzed. The viral load corresponding to the cross-point between sensitivity and specificity was considered the most efficient cut-off value.</p><p id="par0115" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Retrospective follow-up study:</span> the purpose of the retrospective follow-up study was to analyze the usefulness of the EBV load variation as PTLD indicator. The diagnostic ability of the EBV load kinetic variation for detecting total PTLD was evaluated in samples taken before and at the moment of the diagnosis for PTLD cases, and between successive samples for organ recipients without a PTLD history. The analysis was run on paired PBMC and plasma samples.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Statistical analysis</span><p id="par0120" class="elsevierStylePara elsevierViewall">Sensitivity, specificity, positive and negative predictive values were calculated applying the Describe program, version 2.41, from the software package WinPEPI, version 11.14.</p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Results</span><p id="par0125" class="elsevierStylePara elsevierViewall">The EBV load measured in PBMC, plasma and OLT samples from transplant patients with and without PTLD diagnosis is shown in <a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a>A–C, respectively.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Clinical validation</span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Transversal design</span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Peripheral blood mononuclear cells</span><p id="par0130" class="elsevierStylePara elsevierViewall">The analysis of the ability of PBMC-measured EBV load to identify PTLD is shown in <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>. The highest diagnostic efficacy for the detection of total PTLD is achieved at a cut-off value of 1.08<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC (A); for advanced PTLD, at a cut-off of 1.60<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC (B), and for neoplastic PTLD, at a cut-off of 2.47<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC (C).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Plasma</span><p id="par0135" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a> describes the sensitivity and specificity of EBV levels in plasma samples for PTLD diagnosis. The EBV load in plasma samples showed low sensitivity and high specificity to detect total PTLD (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>A). While increased sensitivity, maintaining high specificity, was observed for the detection of advanced PTLD (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>B), similar results were obtained when analyzing only neoplastic PTLD (data not shown).</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Lymphoid tissue</span><p id="par0140" class="elsevierStylePara elsevierViewall">The best relations between sensitivity (Se) and specificity (Sp) for the detection of total, advanced or neoplastic PTLD were obtained at cut-off values of 2.30<span class="elsevierStyleHsp" style=""></span>log (Se<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>57.4<span class="elsevierStyleHsp" style=""></span>% and Sp<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>55.5<span class="elsevierStyleHsp" style=""></span>%), 2.60<span class="elsevierStyleHsp" style=""></span>log (Se<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>63.6<span class="elsevierStyleHsp" style=""></span>% and Sp<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>66.7<span class="elsevierStyleHsp" style=""></span>%) or 4.48<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> cells (Se<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>100<span class="elsevierStyleHsp" style=""></span>% and Sp<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>100<span class="elsevierStyleHsp" style=""></span>%), respectively (data not shown).</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Combination of several samples</span><p id="par0145" class="elsevierStylePara elsevierViewall">In order to improve the diagnostic performance for PTLD detection, the combination of the EBV load measured in different anatomical sites of viral persistence was analyzed (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). The most effective total PTLD detection was obtained by co-measuring the EBV load in PBMC and plasma. However, the incorporation of the OLT viral load did not improve diagnostic eficcacy.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Retrospective follow-up</span><p id="par0150" class="elsevierStylePara elsevierViewall">Results from the retrospective follow-up study are shown in <a class="elsevierStyleCrossRef" href="#fig0020">Figure 4</a> and <a class="elsevierStyleCrossRefs" href="#tbl0015">Tables 3 and 4</a>. The determination of the kinetic load variation increased diagnostic efficacy compared to the use of a single cut-off value (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>). Moreover, the co-measurement of the kinetic variation in more than one clinical sample improved the diagnostic ability of the assay.</p><elsevierMultimedia ident="fig0020"></elsevierMultimedia><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><elsevierMultimedia ident="tbl0025"></elsevierMultimedia></span></span></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Discussion</span><p id="par0155" class="elsevierStylePara elsevierViewall">Many of the publications in which EBV load was used to identify PTLD were based on patients diagnosed with neoplastic categories<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">14,15</span></a>. This would explain the high threshold levels applied by different laboratories, which could be considered consistent with those proposed in the present study for identifying neoplastic lymphoproliferations (transversal study). Thus, considering the present data, the highest EBV levels would be particularly associated with neoplasia. The definition of high load based on a cut-off value that detects neoplastic cases may not be useful for prevention purposes. In such sense, few reports exist that describe the amount of EBV associated with the different categories of PTLD<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">21</span></a>. According to the present results, early PTLD stages tend to show a number of EBV genomes in all anatomical sites of viral persistence, lower than that observed in neoplastic categories (transversal study).</p><p id="par0160" class="elsevierStylePara elsevierViewall">Therefore, considering that the aim of the EBV quantification in transplant patients is to detect the onset of lymphoproliferation, we wondered which monitoring strategy would be the best. Thus, a cut-off of 2.48<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC would point to neoplastic PTLD patients, but many cases with less advanced stages would be missed. A cut-off value of 1.08<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC would detect the majority of organ recipients with PTLD, but would also include many without PTLD.</p><p id="par0165" class="elsevierStylePara elsevierViewall">It has already been proposed that a high EBV load in plasma is a more specific PTLD marker than its determination in PBMC<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">23</span></a>; however, it is also less sensitive<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">1</span></a>. According to the present transversal study, the detection of EBV DNA in plasma samples appears to be a sensitive and specific indicator of advanced PTLD, albeit very insensitive to identify early phases. In addition, as noted in the retrospective follow-up (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>), two patients showed undetectable EBV load in plasma at PTLD diagnosis, one in category 1 (case F) and one even in a neoplastic stage (case E).</p><p id="par0170" class="elsevierStylePara elsevierViewall">The levels of EBV in lymphoid tissue are not usually analyzed to detect PTLD since peripheral blood samples are less invasive and more easily available. In this respect, the present data showed that a high amount of EBV DNA in lymphoid tissue exhibits the highest ability for neoplastic PTLD detection, but not for less advanced categories.</p><p id="par0175" class="elsevierStylePara elsevierViewall">In most reports, the determination of an increased EBV load in a single blood sample type is used for PTLD identification<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">1</span></a>; however it has also been suggested that the simultaneous evaluation of whole blood and plasma samples allows for better diagnosis and monitoring, and may be used to rule out their presence<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">23</span></a>. Thus, among all the combinations analyzed in the present report, the simultaneous measurement of EBV load in PBMC and plasma resulted in a greater diagnostic efficacy regarding the quantification of a single sample type (transversal study).</p><p id="par0180" class="elsevierStylePara elsevierViewall">Moreover, as the retrospective follow-up showed the kinetic variation of the EBV levels measured in PBMC or plasma, it evidenced a better diagnostic ability than the use of a single cut-off value; these results are consistent with already reported data<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">6</span></a>. Furthermore, an increased risk of PTLD was demonstrated when detecting viral level variations in patients with persistent high EBV loads<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">2</span></a>.</p><p id="par0185" class="elsevierStylePara elsevierViewall">Therefore, it has been concluded that the best strategy to monitor transplant patients, regarding the detection of the early stages of PTLD and the risk of progressing to neoplastic categories would include the following algorithm. Initially, it includes the monitoring of the EBV load in PBMC, taking into account that:<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">(1)</span><p id="par0190" class="elsevierStylePara elsevierViewall">An EBV load below 1.08<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC implies low risk. Thus, the patient's routine monitoring should be continued.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">(2)</span><p id="par0195" class="elsevierStylePara elsevierViewall">An EBV load between 1.08<span class="elsevierStyleHsp" style=""></span>log and 2.48<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC involves an increased risk. A more frequent monitoring of the EBV load in PBMC is required to detect a kinetic variation, plus the monitoring of viral levels in plasma. The detection of a kinetic variation in PBMC and/or an EBV load in plasma greater than 2<span class="elsevierStyleHsp" style=""></span>log gEq/ml involves high PTLD risk.</p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">(3)</span><p id="par0200" class="elsevierStylePara elsevierViewall">An EBV load above 2.48<span class="elsevierStyleHsp" style=""></span>log gEq per 10<span class="elsevierStyleSup">5</span> PBMC plus the detection of viral levels greater than 2.52<span class="elsevierStyleHsp" style=""></span>log gEq/ml in plasma imply a high risk of neoplastic PTLD. The greater the EBV load and/or the simultaneous detection of a kinetic variation, the greater the risk of neoplastic PTLD stages.</p></li></ul></p><p id="par0205" class="elsevierStylePara elsevierViewall">It should be borne in mind that the algorithm requires some consideration. Firstly, the overlap in the EBV DNA levels in PBMC among transplant patients with and without PTLD. It should be noted that according to the present results and coinciding with other authors<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">14</span></a>, not all EBV loads defined as “high” imply the development of PTLD.</p><p id="par0210" class="elsevierStylePara elsevierViewall">Carefully monitoring an organ recipient with a low or moderate EBV load is also suggested, since a small increase in viral levels may be associated with PTLD, as was observed in this study and previously reported ones<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">16</span></a>.</p><p id="par0215" class="elsevierStylePara elsevierViewall">The suggested algorithm aims to identify PTLD in the most effective way; however there are patients with PTLD that remain undetected and recipients without PTLD who are included as risky. This points to the need for more specific markers that, when combined with the viral load, result in a more accurate selection of cases of incipient PTLD, allowing to reverse lymphoproliferation in its initial stages.</p><p id="par0220" class="elsevierStylePara elsevierViewall">It should be mentioned that the study presented some limitations. One of them is the variety of transplanted organs included, as they show different PTLD prevalence. However, as the EBV levels in healthy carriers were known<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">5</span></a>, the initial point of rising load (shared by all the transplanted organ groups) could be identified. Furthermore, the number of patients included into each PTLD category was quite different, being the initial stages of PTLD (category 1) the broader. Such category 1 just depicted the beginning of the lymphoproliferation process, which was the aim of the present study; however, all stages of the process were analyzed separately in order to describe the differences among them.</p><p id="par0225" class="elsevierStylePara elsevierViewall">Finally, considering that the determination of the EBV load lacks a gold standard strategy worldwide, this paper provides an in-house methodology, which is analytical, clinically validated, less expensive and more accessible than commercial assays. Thus, it may represent an initial, but very helpful step for the monitoring of transplant patients, especially in low resource settings, where commercial kits are not affordable.</p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Ethical disclosures</span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Protection of human and animal subjects</span><p id="par0230" class="elsevierStylePara elsevierViewall">The authors declare that the procedures followed were in accordance with the regulations of the responsible Clinical Research Ethics Committee and in accordance with those of the World Medical Association and the Helsinki Declaration.</p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Confidentiality of data</span><p id="par0235" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work centre on the publication of patient data.</p></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Right to privacy and informed consent</span><p id="par0240" class="elsevierStylePara elsevierViewall">The authors must have obtained the informed consent of the patients and/or subjects mentioned in the article. The author for correspondence must be in possession of this document.</p></span></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Conflict of interest</span><p id="par0245" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres680254" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec686106" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres680255" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec686105" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:7 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Patients and samples" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Transversal study design" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Retrospective follow-up study design" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "DNA extraction" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "EBV DNA quantification" ] 5 => array:2 [ "identificador" => "sec0040" "titulo" => "Clinical validation" ] 6 => array:2 [ "identificador" => "sec0045" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0050" "titulo" => "Results" "secciones" => array:1 [ 0 => array:3 [ "identificador" => "sec0055" "titulo" => "Clinical validation" "secciones" => array:2 [ 0 => array:3 [ "identificador" => "sec0060" "titulo" => "Transversal design" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Peripheral blood mononuclear cells" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "Plasma" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "Lymphoid tissue" ] 3 => array:2 [ "identificador" => "sec0080" "titulo" => "Combination of several samples" ] ] ] 1 => array:2 [ "identificador" => "sec0085" "titulo" => "Retrospective follow-up" ] ] ] ] ] 7 => array:2 [ "identificador" => "sec0090" "titulo" => "Discussion" ] 8 => array:3 [ "identificador" => "sec0095" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0100" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0105" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0110" "titulo" => "Right to privacy and informed consent" ] ] ] 9 => array:2 [ "identificador" => "sec0115" "titulo" => "Conflict of interest" ] 10 => array:2 [ "identificador" => "xack229395" "titulo" => "Acknowledgements" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-08-21" "fechaAceptado" => "2016-02-21" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec686106" "palabras" => array:6 [ 0 => "Epstein–Barr virus" 1 => "Early PTLD detection" 2 => "Lymphoma" 3 => "Real-time PCR" 4 => "Transplant patients" 5 => "Viral load" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec686105" "palabras" => array:6 [ 0 => "Virus <span class="elsevierStyleItalic">Epstein-Barr</span>" 1 => "Detección temprana de PTLD" 2 => "Linfoma" 3 => "PCR en tiempo real" 4 => "Pacientes trasplantados" 5 => "Carga viral" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">High levels of circulating EBV load are used as a marker of post-transplant lymphoproliferative disorders (PTLD). There is no consensus regarding the threshold level indicative of an increase in peripheral EBV DNA. The aim of the study was to clinically validate a developed EBV quantification assay for early PTLD detection.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Transversal study: paired peripheral blood mononuclear cells (PBMC), plasma and oropharyngeal lymphoid tissue (OLT) from children undergoing a solid organ transplant with (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>58) and without (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>47) PTLD. Retrospective follow-up: 71 paired PBMC and plasma from recipients with (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6) and without (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6) PTLD history. EBV load was determined by real-time PCR. The diagnostic ability to detect all PTLD (categories 1–4), advanced PTLD (categories 2–4) or neoplastic PTLD (categories 3 and 4) was estimated by analyzing the test performance at different cut-off values or with a load variation greater than 0.5<span class="elsevierStyleHsp" style=""></span>log units.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The higher diagnostic performance for identifying all, advanced or neoplastic PTLD, was achieved with cut-off values of 1.08; 1.60 and 2.47<span class="elsevierStyleHsp" style=""></span>log EBV<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> PBMC or 2.30; 2.60; 4.47<span class="elsevierStyleHsp" style=""></span>log<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> OLT cells, respectively. EBV DNA detection in plasma showed high specificity but low (all categories) or high (advanced/neoplastic categories) sensitivity for PTLD identification. Diagnostic performance was greater when: (1) a load variation in PBMC or plasma was identified; (2) combining the measure of EBV load in PBMC and plasma.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The best diagnostic ability to identify early PTLD stages was achieved by monitoring EBV load in PBMC and plasma simultaneously; an algorithm was proposed.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">La carga alta del virus <span class="elsevierStyleItalic">Epstein-Barr</span> se utiliza como un marcador de desórdenes linfoproliferativos postrasplante (<span class="elsevierStyleItalic">post-transplant lymphoproliferative disorders</span> [PTLD]). El objetivo de este estudio fue validar clínicamente un ensayo de cuantificación del virus <span class="elsevierStyleItalic">Epstein-Barr</span> para la detección temprana de PTLD.</p><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se efectuó un estudio transversal en el que se analizaron muestras pareadas de células mononucleares periféricas (CMP), de plasma y de tejido linfoide orofaríngeo de niños con trasplante de órgano sólido, con PTLD (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>58) y sin PTLD (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>47). En el seguimiento retrospectivo se incluyeron 71 muestras pareadas de CMP y de plasma de trasplantados, con PTLD (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6) y sin PTLD (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6). La carga viral se determinó por PCR en tiempo real. Se estimó la capacidad diagnóstica para detectar PTLD (categorías: todas <span class="elsevierStyleItalic">vs</span>. avanzadas <span class="elsevierStyleItalic">vs</span>. neoplásicas) analizando diferentes valores de corte o una variación de carga mayor de 0,5 logaritmos.</p><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">El mayor desempeño diagnóstico para identificar todos los PTLD, los avanzados y los neoplásicos, se obtuvo con valores de corte de 1,08; 1,60 y 2,47 log copias/10<span class="elsevierStyleSup">5</span> en CMP y de 2,30; 2,60 y 4,48 log copias/10<span class="elsevierStyleSup">5</span> en células de tejido linfoide orofaríngeo, respectivamente. La detección del ADN del virus <span class="elsevierStyleItalic">Epstein-Barr</span> en el plasma mostró una especificidad alta, pero una sensibilidad baja (todas las categorías) o alta (categorías avanzadas o neoplásicas) para identificar PTLD. Se observó el desempeño diagnóstico más alto en las siguientes condiciones: <span class="elsevierStyleItalic">1</span>) al identificar una variación de carga en CMP o en plasma; <span class="elsevierStyleItalic">2</span>) combinando la medición de la carga viral en CMP y en plasma.</p><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">La mejor capacidad diagnóstica para identificar las etapas tempranas de los PTLD se logró mediante el seguimiento simultáneo de la carga viral en CMP y en plasma; se propone un algoritmo.</p></span>" ] ] "multimedia" => array:9 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1401 "Ancho" => 2522 "Tamanyo" => 137904 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">EBV load in the transplanted population. (A) EBV load in peripheral blood mononuclear cells, PBMC; (B) EBV load in plasma; (C) EBV load in oropharyngeal lymphoid tissue cells, OLT.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1485 "Ancho" => 2530 "Tamanyo" => 228506 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Analysis of the EBV load from PBMC samples. The best diagnostic performance of the PBMC EBV load to detect different PTLD categories required increasing cut-off values. (A) Total PTLD: included categories 1–4; (B) advanced PTLD: categories 2–4; (C) neoplastic PTLD: categories 3 and 4.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 697 "Ancho" => 2532 "Tamanyo" => 132852 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Analysis of the EBV load from plasma samples. The plasma EBV load showed high specificity to detect all PTLD; while an increasing sensitivity was noted as PTLD stages progressed. Total PTLD: included categories 1–4 (A); advanced PTLD: categories 2–4 (B).</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1824 "Ancho" => 3396 "Tamanyo" => 442879 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Kinetics of EBV load in PBMC and plasma from transplant patients. Recipients with PTLD history: (A–F) Patients without PTLD history: (G–L) FLH: follicular lymphoid hyperplasia. PH: plasmacytic hyperplasia. HL: Hodgkin lymphoma. DLCBL: Diffuse large B cell lymphoma. IS: immunosuppression. IM: infectious mononucleosis. KS: Kaposi's sarcoma. Tx: time of transplantation. EBV: detection of primary EBV infection. (■) EBV load from PBMC; (▴) EBV load from plasma; <span class="elsevierStyleItalic">x</span> axis: sampling times.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">The age of the transplant population ranged between 1 and 18 years (mean: 9.0 years) and the male to female rate was 1.1.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="table-head ; entry_with_role_rowhead " align="left" valign="top" scope="col">Transplanted organ \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Mean of the age at transplant (years) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " colspan="2" align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Histology</th><th class="td" title="table-head " align="left" valign="top" scope="col">Mean of the time between transplant and PTLD diagnosis (month) \t\t\t\t\t\t\n \t\t\t\t</th></tr><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Non-PTLD<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> (n) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PTLD<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> (n) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">LIVER (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>79) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.0 (0.5–11) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">42 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">37 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">66 (20–156) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">KIDNEY (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>24) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.4 (2–12) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">54 (6–132) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HEART (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9.5 (9–10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">66 (60–72) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1116578.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">All patients presented a histological diagnosis of follicular lymphoid hyperplasia.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">The PTLD cases included: Category 1: 40 lymphoid hyperplasia and 2 infectious mononucleosis-like PTLD; Category 2: 8 polymorphic and polyclonal hyperplasia; Category 3: 4 immunoblastic and 2 Burkitt lymphomas, and Category 4: 2 Hodgkin lymphomas.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Description of the transplant population</p>" ] ] 5 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">gEq: EBV genome equivalents.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Cut-off value \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sensitivity<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Specificity<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PPV<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">NPV<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">d</span></a> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">≥Log<span class="elsevierStyleHsp" style=""></span>1.08<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> PBMC<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>≥Log<span class="elsevierStyleHsp" style=""></span>2.00/ml plasma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">87.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">70.0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">≥Log<span class="elsevierStyleHsp" style=""></span>1.08<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> PBMC<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>≥Log<span class="elsevierStyleHsp" style=""></span>2.30<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> OLT<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">e</span></a> cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">67.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">52.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">80.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">≥Log<span class="elsevierStyleHsp" style=""></span>1.08<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> PBMC<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>≥Log<span class="elsevierStyleHsp" style=""></span>2.00<span class="elsevierStyleHsp" style=""></span>gEq/ml plasma<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>≥Log<span class="elsevierStyleHsp" style=""></span>2.30<span class="elsevierStyleHsp" style=""></span>gEq/10<span class="elsevierStyleSup">5</span> OLT<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">e</span></a> cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">72.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">47.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">79.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">34.6 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1116576.png" ] ] ] "notaPie" => array:5 [ 0 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Sensitivity<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>[Number of true positives/(Number of true positives<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Number of false negatives)]<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100.</p>" ] 1 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Specificity<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>[Number of true negatives/(Number of true negatives<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Number of false positives)]<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100.</p>" ] 2 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0025">Positive predictive value<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>[Number of true positives/(Number of true positives<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Number of false positives)]<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100.</p>" ] 3 => array:3 [ "identificador" => "tblfn0030" "etiqueta" => "d" "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Negative predictive value<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>[Number of true negatives/(Number of true negatives<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Number of false negatives)]<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>100.</p> <p class="elsevierStyleNotepara" id="npar0035">For calculations, the histological diagnosis was considered the gold standard to which the EBV quantification load was compared.</p>" ] 4 => array:3 [ "identificador" => "tblfn0035" "etiqueta" => "e" "nota" => "<p class="elsevierStyleNotepara" id="npar0040">OLT: oropharyngeal lymphoid tissue.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Diagnostic performance of the EBV load measured on several sample types for PTLD detection</p>" ] ] 6 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0125" class="elsevierStyleSimplePara elsevierViewall">PH: plasmacytic hyperplasia (Category 1 of PTLD); HL: Hodgkin lymphoma (Category 4 of PTLD); DLCBL: Diffuse large B cell lymphoma (Category 3 of PTLD).</p><p id="spar0145" class="elsevierStyleSimplePara elsevierViewall">NA: Not applicable because EBV load remained not detectable.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histological diagnosis \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kinetic load variation<a class="elsevierStyleCrossRef" href="#tblfn0040"><span class="elsevierStyleSup">a</span></a> PBMC (log differences) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kinetic load variation<a class="elsevierStyleCrossRef" href="#tblfn0040"><span class="elsevierStyleSup">a</span></a> Plasma (log differences) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PH<br>HL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−1.34)<br>Positive (0.70) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (1.73)<br>Negative (0.30)<a class="elsevierStyleCrossRef" href="#tblfn0045"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">B \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DLCBL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (0.37) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (1.16) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">C \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DLCBL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.55) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (2.47) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">D \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.98) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">E \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">DLCBL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.83) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (0.15) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">PH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.77) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1116577.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0040" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0045">Positive kinetic variation: ≥0.5<span class="elsevierStyleHsp" style=""></span>log rise in EBV load; Negative kinetic variation: <0.5<span class="elsevierStyleHsp" style=""></span>log rise or a decrease (indicated by a minus sign) in EBV load.</p>" ] 1 => array:3 [ "identificador" => "tblfn0045" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0050">Although EBV load did not show a positive kinetic variation, when HL was diagnosed it remained in high levels, similar to those detected at the moment of PH identification.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Description of the kinetic variation of EBV load in PBMC and plasma from transplant patients at PTLD diagnosis</p>" ] ] 7 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0135" class="elsevierStyleSimplePara elsevierViewall">FLH: follicular lymphoid hyperplasia.</p><p id="spar0140" class="elsevierStyleSimplePara elsevierViewall">NA: Not applicable because viral load remained not detectable.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Histological diagnosis \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kinetic load variation<a class="elsevierStyleCrossRef" href="#tblfn0050"><span class="elsevierStyleSup">a</span></a> PBMC (log differences) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kinetic load variation<a class="elsevierStyleCrossRef" href="#tblfn0050"><span class="elsevierStyleSup">a</span></a> Plasma (log differences) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">G \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−0.96)<br>Positive (1.46)<br>Negative (−0.74)<br>Positive (0.64)<br>Negative (−0.03)<br>Negative (−0.93) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA<br>NA<br>NA<br>NA<br>NA<br>NA \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">H \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−0.97)<br>Positive (2.45)<br>Negative (−1.33)<br>Negative (−0.60) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA<br>NA<br>NA<br>NA \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">I \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.54)<br>Negative (−0.11)<br>Positive (1.48)<br>Negative (−0.34) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Positive (0.63)<br>Negative (−0.63)<br>NA<br>NA \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">J \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−1.24)<br>Negative (−1.73)<br>Positive (2.78)<br>Negative (−0.95)<br>Positive (0.13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−2.13)<br>NA<br>NA<br>NA<br>Negative (0.12) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">K \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−1.39)<br>Positive (0.74)<br>Negative (0.31)<br>Negative (−0.62)<br>Negative (−0.61) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (0.37)<br>Negative (−0.37)<br>NA<br>NA<br>NA \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">FLH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (0.12)<br>Negative (−0.97)<br>Negative (0.40)<br>Negative (0.04) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Negative (−0.37)<br>Positive (1.10)<br>Negative (−1.10)<br>NA \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1116579.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0050" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0055">Positive kinetic variation: ≥0.5<span class="elsevierStyleHsp" style=""></span>log rise in EBV load. Negative kinetic variation: <0.5<span class="elsevierStyleHsp" style=""></span>log rise or a decrease (indicated by a minus sign) in EBV load.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">Description of the kinetic variation of EBV load in PBMC and plasma from transplant patients without a PTLD diagnosis</p>" ] ] 8 => array:8 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at5" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Kinetic load variation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sensitivity \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Specificity \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">PPV<a class="elsevierStyleCrossRef" href="#tblfn0055"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">NPV<a class="elsevierStyleCrossRef" href="#tblfn0060"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PBMC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">83.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">57.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">31.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">93.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Plasma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">80 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">80.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">44.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">95.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">PBMC<span class="elsevierStyleHsp" style=""></span>+<span class="elsevierStyleHsp" style=""></span>Plasma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">83.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">81.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">55.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">94.7 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1116575.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0055" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0060">Positive predictive value.</p>" ] 1 => array:3 [ "identificador" => "tblfn0060" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0065">Negative predictive value.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0120" class="elsevierStyleSimplePara elsevierViewall">Diagnostic performance of the kinetic variation of EBV load for PTLD detection</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:23 [ 0 => array:3 [ "identificador" => "bib0120" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quantification of <span class="elsevierStyleItalic">Epstein–Barr virus</span>-DNA load in lung transplant recipients: a comparison of plasma versus whole blood" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "N.A. Bakker" 1 => "E.A. Verschuuren" 2 => "N.J. Veeger" 3 => "W. van der Bij" 4 => "G.W. van Imhoff" 5 => "C.G. Kallenberg" 6 => "B.G. Hepkema" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.healun.2007.10.008" "Revista" => array:6 [ "tituloSerie" => "J Heart Lung Transplant" "fecha" => "2008" "volumen" => "27" "paginaInicial" => "7" "paginaFinal" => "10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18187080" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0125" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic high <span class="elsevierStyleItalic">Epstein–Barr viral</span> load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:8 [ 0 => "M.A. Bingler" 1 => "B. Feingold" 2 => "S.A. Miller" 3 => "M.G. Michaels" 4 => "M. Green" 5 => "R.M. Wadowsky" 6 => "D.T. Rowe" 7 => "S.A. Webber" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2007.02080.x" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2008" "volumen" => "8" "paginaInicial" => "442" "paginaFinal" => "445" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18211510" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0130" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective study on modulation of immunosuppression for <span class="elsevierStyleItalic">Epstein–Barr virus</span> reactivation in pediatric patients who underwent unrelated hematopoietic stem-cell transplantation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:11 [ 0 => "S. Cesaro" 1 => "A. Pegoraro" 2 => "G. Tridello" 3 => "E. Calore" 4 => "M. Pillon" 5 => "S. Varotto" 6 => "D. Abate" 7 => "L. Barzon" 8 => "C. Mengoli" 9 => "M. Carli" 10 => "C. Messina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/TP.0b013e3181dd6c0a" "Revista" => array:6 [ "tituloSerie" => "Transplantation" "fecha" => "2010" "volumen" => "89" "paginaInicial" => "1533" "paginaFinal" => "1540" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20463647" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0135" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A semi-quantitative PCR method (SQ-PCR) to measure <span class="elsevierStyleItalic">Epstein–Barr virus</span> load: its application in transplant patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "M.D. Fellner" 1 => "K. Durand" 2 => "M. Correa" 3 => "D. Bes" 4 => "L.V. Alonio" 5 => "A.R. Teyssié" 6 => "M.A. Picconi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Clin Virol" "fecha" => "2003" "volumen" => "28" "paginaInicial" => "323" "paginaFinal" => "330" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14522071" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0140" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Duplex realtime PCR method for <span class="elsevierStyleItalic">Epstein–Barr virus</span> and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.D. Fellner" 1 => "K.A. Durand" 2 => "M.A. Rodríguez" 3 => "L. Irazu" 4 => "L.V. Alonio" 5 => "M.A. Picconi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bjid.2013.07.011" "Revista" => array:6 [ "tituloSerie" => "Braz J Infect Dis" "fecha" => "2014" "volumen" => "18" "paginaInicial" => "271" "paginaFinal" => "280" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24389276" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0145" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Viral dynamics in transplant patients: implications for disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.A. Funk" 1 => "R. Gosert" 2 => "H.H. Hirsch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Lancet Inf Dis" "fecha" => "2007" "volumen" => "7" "paginaInicial" => "460" "paginaFinal" => "472" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0150" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EBV viral load detection in clinical virology" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B. Gärtner" 1 => "J.K. Preiksaitis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcv.2010.03.016" "Revista" => array:6 [ "tituloSerie" => "J Clin Virol" "fecha" => "2010" "volumen" => "48" "paginaInicial" => "82" "paginaFinal" => "90" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20395167" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0155" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Posttransplantation lymphoproliferative disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Green" 1 => "S. Webber" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatr Clin North Am" "fecha" => "2003" "volumen" => "50" "paginaInicial" => "1471" "paginaFinal" => "1491" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14710788" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0160" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Developing a quality system for quantitative laboratory-developed tests" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "T.E. Grys" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Microbiol Newsl" "fecha" => "2011" "volumen" => "33" "paginaInicial" => "179" "paginaFinal" => "185" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0165" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Using <span class="elsevierStyleItalic">Epstein–Barr viral</span> load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.L. Gulley" 1 => "W. Tang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CMR.00006-09" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Rev" "fecha" => "2010" "volumen" => "23" "paginaInicial" => "350" "paginaFinal" => "366" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20375356" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0170" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quantitative <span class="elsevierStyleItalic">Epstein–Barr virus</span> viral load monitoring in pediatric liver transplantation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.Y. Jang" 1 => "K.M. Kim" 2 => "Y.J. Lee" 3 => "S.G. Lee" 4 => "H.S. Chi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2008.07.014" "Revista" => array:6 [ "tituloSerie" => "Transplant Proc" "fecha" => "2008" "volumen" => "40" "paginaInicial" => "2546" "paginaFinal" => "2548" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18929796" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0175" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:10 [ 0 => "N. Kerkar" 1 => "R.A. Morotti" 2 => "R.P. Madan" 3 => "B. Shneider" 4 => "B.C. Herold" 5 => "C. Dugan" 6 => "T. Miloh" 7 => "I. Karabicak" 8 => "J.A. Strauchen" 9 => "S. Emre" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1399-3046.2009.01258.x" "Revista" => array:6 [ "tituloSerie" => "Pediatr Transplant" "fecha" => "2010" "volumen" => "14" "paginaInicial" => "504" "paginaFinal" => "511" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20070559" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0180" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measuring <span class="elsevierStyleItalic">Epstein–Barr virus</span> (EBV) load: the significance and application for each EBV-associated disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H. Kimura" 1 => "Y. Ito" 2 => "R. Suzuki" 3 => "Y. Nishiyama" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/rmv.582" "Revista" => array:6 [ "tituloSerie" => "Rev Med Virol" "fecha" => "2008" "volumen" => "18" "paginaInicial" => "305" "paginaFinal" => "319" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18494041" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0185" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-transplant lymphoproliferative disease and other <span class="elsevierStyleItalic">Epstein–Barr virus</span> diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Kinch" 1 => "G. Oberg" 2 => "J. Arvidson" 3 => "K.I. Falk" 4 => "A. Linde" 5 => "K. Pauksens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/00365540600978906" "Revista" => array:6 [ "tituloSerie" => "Scand J Infect Dis" "fecha" => "2007" "volumen" => "39" "paginaInicial" => "235" "paginaFinal" => "244" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17366054" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0190" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monitoring of <span class="elsevierStyleItalic">Epstein–Barr virus</span> load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Meerbach" 1 => "P. Wutzler" 2 => "R. Häfer" 3 => "F. Zintl" 4 => "B. Gruhn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jmv.21096" "Revista" => array:6 [ "tituloSerie" => "J Med Virol" "fecha" => "2008" "volumen" => "80" "paginaInicial" => "441" "paginaFinal" => "454" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18205222" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0195" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monitoring and modulation of <span class="elsevierStyleItalic">Epstein–Barr virus</span> loads in pediatric transplant patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.J. Orentas" 1 => "D.W. Schauer Jr." 2 => "F.W. Ellis" 3 => "J. Walczak" 4 => "J.T. Casper" 5 => "D.A. Margolis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatr Transplant" "fecha" => "2003" "volumen" => "7" "paginaInicial" => "305" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12890010" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0200" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Epstein Barr virus</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.B. Rickinson" 1 => "E. Kieff" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:7 [ "editores" => "B.N.FieldsD.M.KnipeP.M.Howley" "paginaInicial" => "2656" "paginaFinal" => "2700" "edicion" => "5th ed." "serieVolumen" => "vol. 2" "serieTitulo" => "Fields virology" "serieFecha" => "2007" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0205" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased levels of circulating <span class="elsevierStyleItalic">Epstein–Barr virus</span> (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.A. Riddler" 1 => "M.C. Breinig" 2 => "J.L. McKnight" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1994" "volumen" => "84" "paginaInicial" => "972" "paginaFinal" => "984" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8043879" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0210" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early identification of <span class="elsevierStyleItalic">Epstein–Barr virus</span>-associated post-transplantation lymphoproliferative disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.M. Rooney" 1 => "S.K. Loftin" 2 => "M.S. Holladay" 3 => "M.K. Brenner" 4 => "R.A. Krance" 5 => "H.E. Heslop" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Haematol" "fecha" => "1995" "volumen" => "89" "paginaInicial" => "98" "paginaFinal" => "103" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7833284" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0215" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of quantitative competitive PCR to measure <span class="elsevierStyleItalic">Epstein–Barr virus</span> genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:8 [ 0 => "D.T. Rowe" 1 => "L. Qu" 2 => "J. Reyes" 3 => "N. Jabbour" 4 => "E. Yunis" 5 => "P. Putnam" 6 => "S. Todo" 7 => "M. Green" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Clin Microbiol" "fecha" => "1997" "volumen" => "35" "paginaInicial" => "1612" "paginaFinal" => "1615" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9163497" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0220" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:10 [ 0 => "S. Schubert" 1 => "H. Abdul-Khaliq" 2 => "H.B. Lehmkuhl" 3 => "M. Yegitbasi" 4 => "P. Reinke" 5 => "C. Kebelmann-Betzig" 6 => "K. Hauptmann" 7 => "U. Gross-Wieltsch" 8 => "R. Hetzer" 9 => "F. Berger" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1399-3046.2008.00969.x" "Revista" => array:6 [ "tituloSerie" => "Pediatr Transplant" "fecha" => "2009" "volumen" => "13" "paginaInicial" => "54" "paginaFinal" => "62" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18518912" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0225" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Post-transplant lymphoproliferative disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.H. Swerdlow" 1 => "S.A. Webber" 2 => "A. Chadburn" 3 => "J.A. Ferry" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "WHO classification of tumours of haematopoietic and lymphoid tissues" "paginaInicial" => "343" "paginaFinal" => "350" "edicion" => "4th ed." "serieFecha" => "2008" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0230" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:15 [ 0 => "D.E. Tsai" 1 => "L. Douglas" 2 => "C. Andreadis" 3 => "D.T. Vogl" 4 => "S. Arnoldi" 5 => "R. Kotloff" 6 => "J. Svoboda" 7 => "R.D. Bloom" 8 => "K.M. Olthoff" 9 => "S.C. Brozena" 10 => "S.J. Schuster" 11 => "E.A. Stadtmauer" 12 => "E.S. Robertson" 13 => "M.A. Wasik" 14 => "V.N. Ahya" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2008.02183.x" "Revista" => array:6 [ "tituloSerie" => "Am J Transplant" "fecha" => "2008" "volumen" => "8" "paginaInicial" => "1016" "paginaFinal" => "1024" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18312608" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack229395" "titulo" => "Acknowledgements" "texto" => "<p id="par0255" class="elsevierStylePara elsevierViewall">The authors are indebted to S. Nuñez and J. Campos, for their technical assistance, Drs: C. Gonzalez Cambaceres, P. Bernáldez, J. Ibañez and A. Turconi (“Prof. Dr Juan P. Garrahan” Pediatric Hospital); J. Gregoresky and M. V. Ávila (Austral University Hospital); T. Gonzalez and S. Besga (“Sor María Ludovica” Children's Hospital), J. Trentadue (Favaloro Foundation) for their generous help during sampling, and their commitment to the prevention of PTLD in transplant patients. This project was partially supported by grants from <span class="elsevierStyleGrantSponsor" id="gs1">ANLIS Carlos G. Malbrán</span> (FOCANLIS/2009) (Buenos Aires, Argentina).</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03257541/0000004800000002/v1_201607030039/S0325754116000110/v1_201607030039/en/main.assets" "Apartado" => array:4 [ "identificador" => "37861" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Microbiología clínica y enfermedades infecciosas" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03257541/0000004800000002/v1_201607030039/S0325754116000110/v1_201607030039/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0325754116000110?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 1 | 6 |
2024 October | 58 | 5 | 63 |
2024 September | 92 | 5 | 97 |
2024 August | 69 | 9 | 78 |
2024 July | 65 | 7 | 72 |
2024 June | 62 | 7 | 69 |
2024 May | 61 | 3 | 64 |
2024 April | 68 | 3 | 71 |
2024 March | 76 | 9 | 85 |
2024 February | 41 | 5 | 46 |
2024 January | 41 | 3 | 44 |
2023 December | 49 | 11 | 60 |
2023 November | 57 | 6 | 63 |
2023 October | 73 | 5 | 78 |
2023 September | 41 | 4 | 45 |
2023 August | 54 | 6 | 60 |
2023 July | 74 | 6 | 80 |
2023 June | 70 | 3 | 73 |
2023 May | 93 | 6 | 99 |
2023 April | 73 | 5 | 78 |
2023 March | 44 | 6 | 50 |
2023 February | 51 | 5 | 56 |
2023 January | 33 | 3 | 36 |
2022 December | 36 | 11 | 47 |
2022 November | 43 | 7 | 50 |
2022 October | 38 | 14 | 52 |
2022 September | 37 | 9 | 46 |
2022 August | 43 | 10 | 53 |
2022 July | 54 | 12 | 66 |
2022 June | 32 | 6 | 38 |
2022 May | 87 | 19 | 106 |
2022 April | 76 | 10 | 86 |
2022 March | 76 | 13 | 89 |
2022 February | 69 | 12 | 81 |
2022 January | 67 | 8 | 75 |
2021 December | 35 | 19 | 54 |
2021 November | 40 | 13 | 53 |
2021 October | 37 | 15 | 52 |
2021 September | 29 | 11 | 40 |
2021 August | 34 | 12 | 46 |
2021 July | 24 | 12 | 36 |
2021 June | 25 | 14 | 39 |
2021 May | 18 | 13 | 31 |
2021 April | 55 | 15 | 70 |
2021 March | 29 | 15 | 44 |
2021 February | 15 | 11 | 26 |
2021 January | 33 | 16 | 49 |
2020 December | 21 | 11 | 32 |
2020 November | 16 | 7 | 23 |
2020 October | 13 | 9 | 22 |
2020 September | 19 | 13 | 32 |
2020 August | 20 | 6 | 26 |
2020 July | 16 | 6 | 22 |
2020 June | 21 | 8 | 29 |
2020 May | 36 | 10 | 46 |
2020 April | 25 | 7 | 32 |
2020 March | 39 | 7 | 46 |
2020 February | 32 | 10 | 42 |
2020 January | 37 | 10 | 47 |
2019 December | 38 | 16 | 54 |
2019 November | 27 | 23 | 50 |
2019 October | 25 | 7 | 32 |
2019 September | 38 | 16 | 54 |
2019 August | 16 | 7 | 23 |
2019 July | 15 | 19 | 34 |
2019 June | 36 | 27 | 63 |
2019 May | 56 | 63 | 119 |
2019 April | 36 | 19 | 55 |
2019 March | 15 | 6 | 21 |
2019 February | 18 | 11 | 29 |
2019 January | 23 | 13 | 36 |
2018 December | 17 | 11 | 28 |
2018 November | 24 | 18 | 42 |
2018 October | 26 | 25 | 51 |
2018 September | 29 | 8 | 37 |
2018 August | 9 | 6 | 15 |
2018 July | 5 | 9 | 14 |
2018 June | 15 | 4 | 19 |
2018 May | 7 | 23 | 30 |
2018 April | 5 | 4 | 9 |
2018 March | 8 | 5 | 13 |
2018 February | 3 | 13 | 16 |
2018 January | 12 | 7 | 19 |
2017 December | 4 | 15 | 19 |
2017 November | 9 | 3 | 12 |
2017 October | 16 | 17 | 33 |
2017 September | 11 | 8 | 19 |
2017 August | 5 | 23 | 28 |
2017 July | 10 | 5 | 15 |
2017 June | 19 | 11 | 30 |
2017 May | 16 | 17 | 33 |
2017 April | 14 | 15 | 29 |
2017 March | 20 | 76 | 96 |
2017 February | 17 | 8 | 25 |
2017 January | 9 | 12 | 21 |
2016 December | 22 | 12 | 34 |
2016 November | 27 | 17 | 44 |
2016 October | 39 | 29 | 68 |
2016 September | 50 | 22 | 72 |
2016 August | 77 | 31 | 108 |
2016 July | 46 | 16 | 62 |